NeoPhore

NeoPhore Focuses on Developing Novel Small Molecule Therapies for Cancer Treatment by Stimulating the Immune System. The Company’s Approach Targets Genetic Mechanisms Identified in Clinical and Laboratory Studies as Drivers of Neoantigen Generation and Diversity Across Multiple Cancers. Leveraging These Insights, NeoPhore Aims to Develop Next-Generation Immuno-Oncology Therapies to Improve Clinical Outcomes for Cancer Patients.